An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
NCT07593391
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Phelan-McDermid Syndrome
Interventions
DRUG:
NNZ-2591
Sponsor
Neuren Pharmaceuticals Limited